KSL11h
Utah business titan, philanthropist Spencer F. Eccles honored
Spencer F. Eccles can trace his Utah roots back to the mid-19th century and Scottish immigrants who came to the United States ...
DiMare family gives $35 million to UMass Chan Medical School, the university’s third-largest gift in history
The family foundation’s gift will go to an endowment to fund research into curing ALS and other neurodegenerative diseases at ...
FiercePharma13h
FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout
A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...
Vistagen: Pherine Candidate Proof Of Concept Continues With Fifth Indication
Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...
BioPharma Dive18h
‘It’s not for the faint of heart.’ How 3 CEOs took their biotechs public
Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
STAT20h
Pharmalittle: We’re reading about FDA morale, pharma removing DEI goals, and more
Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...
STAT21h
Two biotechs say they’re using AI to conjure drugs from scratch. Their documents suggest otherwise
A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedicines routinely aggrandize their AI ...
FiercePharma21h
Fierce Pharma Asia—Astellas' investment focus; Mitsubishi Tanabe's buyout; Leqembi's 'expansion phase'
Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...